Internal Medicine: Open Access
Open Access

Kamil Ashour Farhoud

Publications

• Research Article
  Trastuzumab Related Cardio-toxicity in Breast Cancer Patients Single Center Experiences
  Author(s): Kamil Ashour Farhoud and Eaman suud khalifa Kamil Ashour Farhoud and Eaman suud khalifa
  
  Background: Trastuzumab may induce cardio-toxicity which can be clinically identified as decreased left ventricular systolic function with or without symptoms of heart failure. Objectives: To determine the prevalence and potential risk factors of trastuzumab related cardio-toxicity in breast cancer treated patients. Methods: The study was carried out on 78 HER2- positive breast cancer patients who received trastuzumab in the Oncology Department of Al-yarmouk teaching hospital, Baghdad, between September, 2017 and April, 2018. Results: Twenty two (28.2%) patients developed a significant declining in le ft ventricular systolic function (27.6% of early breast cancer patients and 29% of patients with metastatic disease). Seven of 78 patients (8.9%) developed symptomatic heart failure. Patients with tr.. View More»
  DOI: 10.4172/2165-8048.1000275

  Abstract PDF

Relevant Topics